Top Back to top

Allogenic Hematopoietic Stem Cell Transplantation for Adult Sickle Cell Disease: A registry study on behalf of the EBMT Pediatric Disease Working Party

Paediatric Diseases Working Party (PDWP)
Type d'étude:
Numéro de l'étude:
Type de traitement à base de cellules souches:
Titre court:
Objectif principal:
To report the outcomes of adult SCD patients undergoing allo-HSCT from an HLA-identical, related donor or haploidentical and unrelated donors, with the main end point being the successful engraftment and overall survival, disease free survival at a certain point in time.
Principaux critères d'inclusion:
All consecutive SCD patients older than 17 years who underwent allo-HSCT between Jan 2010 and June 2020, regardless of conditioning will be included.
Investigateur principal:
Can Boga
Coordinateur EBMT de l'étude:
Arnaud Dalissier
E-mail du coordinateur de l'étude: